VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
OACCOaktree Acquisition Corp. III Life Sciences
$10.67$262M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksOACCP/E History

OACC logoOaktree Acquisition Corp. III Life Sciences (OACC) P/E Ratio History

Undervalued

Trading at 35.6x vs 5Y avg 44.5x · 0th percentile · Below historical baseline · Data 2025–2026

Current P/E (TTM)
35.6x
-20% vs 5Y avg
5Y Avg P/E
44.5x
Median 50.0x
5Y Percentile
0th
Lower end of range
PEG Ratio
N/A
5-Year P/E Range
35.6x
Min39.0xMedian50.0xMax50.0x
TTM EPS$0.34
Price$10.67
Earnings Yield2.81%
EPS Growth (1Y)453.5%
EPS Growth (5Y)N/A

Loading P/E history...

P/E Ratio Analysis

As of June 28, 2026, Oaktree Acquisition Corp. III Life Sciences (OACC) trades at a price-to-earnings ratio of 35.6x, with a stock price of $10.67 and trailing twelve-month earnings per share of $0.34.

The current P/E is 20% below its 5-year average of 44.5x. Over the past five years, OACC's P/E has ranged from a low of 39.0x to a high of 50.0x, placing the current valuation at the 0th percentile of its historical range.

Compared to the Financial Services sector median P/E of 14.2x, OACC trades at a 151% premium to its sector peers. The sector includes 801 companies with P/E ratios ranging from 0.0x to 157.7x.

Relative to the broader market, OACC commands a significant premium over the S&P 500 median P/E of 25.3x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.

For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our OACC DCF Valuation Calculator →

Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.

OACC Cross-Benchmark Valuation

How does the current P/E compare to sector peers and the broader market?

vs. Financial Services
35.6vs14.2
+151%
Above Sector
vs. S&P 500
35.6vs25.3
+41%
Above Market
PEG Analysis
N/A
P/E ÷ EPS Growth
Based on 454% EPS growth (1Y)

OACC P/E vs Peers

Healthcare and life sciences SPACs peers sorted by market cap

CompanyMarket CapP/E RatioPEG RatioEPS Growth (1Y)
NVAX logoNVAXNovavax, Inc.
$1B3.5Lowest-Best+307%Best

Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.

OACC Historical P/E Data (2025–2026)

Quarterly P/E ratios calculated from closing price and TTM EPS

QuarterPeriod EndPriceTTM EPSP/E Ratiovs Avg
FY2026 Q1-$10.62$0.2739.0x-12%
FY2025 Q3-$10.51$0.2150.0x+12%

Average P/E for displayed period: 44.5x

Export Data
Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

1+ years return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

OACC — Frequently Asked Questions

Quick answers to the most common questions about buying OACC stock.

What is OACC's P/E ratio?

Oaktree Acquisition Corp. III Life Sciences (OACC) trailing twelve-month P/E ratio is 35.6x, based on TTM diluted EPS of $0.34. The 5-year average P/E is 44.5x and the historical range spans 39.0x to 50.0x.

Is OACC stock overvalued or undervalued?

OACC trades at 35.6x P/E, near its 5-year average of 44.5x. The 0th percentile ranking within the 39.0x–50.0x historical range places valuation within normal bounds.

Is OACC stock expensive?

OACC is fairly valued relative to its own history. The current P/E of 35.6x is near the 5-year average of 44.5x (0th percentile of historical range).

What is OACC's historical P/E range?

Over the past 5 years, OACC's P/E ratio has ranged from 39.0x to 50.0x, with a median of 50.0x and an average of 44.5x. The current P/E of 35.6x places the stock at the 0th percentile of this range. Full historical data spans 2025–2026.

How does OACC's P/E compare to the S&P 500?

OACC trades at 35.6x P/E versus the S&P 500 median of 25.3x. The 41% premium to the market typically reflects higher expected earnings growth or quality.

How does OACC's valuation compare to Financial Services peers?

Oaktree Acquisition Corp. III Life Sciences P/E of 35.6x compares to the Financial Services sector median of 14.2x. The premium reflects expected growth above peers or stronger fundamentals. See the peer comparison table on this page for ticker-by-ticker P/E and PEG.

What is OACC's PEG ratio?

OACC PEG ratio is N/A, based on a P/E of 35.6x and EPS growth of 453.5%. PEG normalises P/E by growth and helps compare stocks with different earnings trajectories.

What is OACC's earnings yield?

OACC earnings yield is 2.81%, the inverse of its 35.6x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.

OACC P/E Ratio History (2025–2026)

Quarterly valuation multiple from closing price and trailing EPS

Current39.0x
Period Avg44.5x
Range39.0x - 50.0x
Change-22%
2 quartersSep 30, 2025 - Mar 31, 2026